KevinMD July 22, 2024
On my outpatient clinical rotations last year, I saw ample management of heart disease and smoking cessation counseling. I also saw the annual physicals and checkups. But what surprised me was how many patients were on medications that were just now becoming more mainstream. I’m sure you’ve heard of one in particular—Ozempic. But it wasn’t just Ozempic. There was also Wegovy and Mounjaro. These medications, in the family of semaglutides, were just starting to become more well-known not just for their management of diabetes but also for the dramatic weight loss they led to in some patients. Many of these patients had been diagnosed with their diabetes just a few months prior and had not been started on trials of...
Today's Sponsors
Today's Sponsor